Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Hertel Exophthalmometry Values in Mexican Adults

NCT07705061 · tracked via the Priya Life Science Mexico tracker
Phase
Observational
Started
2026-04-21
Last updated
2026-07-15

Condition(s) studied

ExophthalmometryNormal Exophthalmometric Values

Investigational drug(s) / intervention(s)

Hertel Exophthalmometry

Hertel Exophthalmometry: Standardized bilateral Hertel exophthalmometry performed using a Hertel exophthalmometer to measure globe protrusion.

Study summary

Proptosis assessment using Hertel exophthalmometry is an essential part of the ophthalmic examination, but normal reference values vary among different populations. This observational study aims to establish normative Hertel exophthalmometry values in Mexican adults and to evaluate their association with demographic characteristics (such as age and sex) and systemic diseases. Healthy adult participants and adults with selected systemic conditions will undergo standardized Hertel exophthalmometry measurements. The findings are expected to provide population-specific reference values that may improve the clinical assessment of orbital diseases in the Mexican population.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Adults aged 18 years or older. * Mexican participants or individuals who self-identify as Mexican. * Ability to understand the study procedures and provide written informed consent. * Ability to undergo bilateral Hertel exophthalmometry. * Participants with or without previously diagnosed systemic diseases. Exclusion Criteria: * Active thyroid eye disease * History of orbital trauma or orbital fracture. * Previous orbital surgery, orbital decompression, or surgery that may alter globe position. * Presence or history of an orbital tumor, orbital inflammation, or orbital infection. * Craniofacial abnormalities or facial asymmetry that may interfere with Hertel exophthalmometry. * Ocular or eyelid conditions that prevent accurate positioning or measurement with the Hertel exophthalmometer. * Inability to cooperate with the examination or obtain a reliable exophthalmometry measurement.

Primary outcome measure(s)

  • Hertel Exophthalmometry Value — At baseline
    Bilateral Hertel exophthalmometry measurements (millimeters) obtained using a standardized Hertel exophthalmometer. Normative values will be estimated and summarized for the study population.

Trial sites (1)

FacilityCityRegionStatus
✔ Instituto de Oftalmología Fundación Conde de Valenciana IAP Mexico City Mexico City Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07705061 on ClinicalTrials.gov ↗ ← All trials in Mexico